SCHEMBL2197276

SCHEMBL2197276

BrCCC1CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30688061 1.00
SCHEMBL963751 0.93
SCHEMBL10743755 0.91 HPGD (0.36)
SCHEMBL11565964 0.87
SCHEMBL2198239 0.86
SCHEMBL2199616 0.84 EPHX1 (0.47)
SCHEMBL2002222 0.84 EPHX1 (0.42)
SCHEMBL2197798 0.79 EPHX1 (0.42)
SCHEMBL6450396 0.79 EPHX1 (0.50)
SCHEMBL8280 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101311176-A Isoquinoline compounds, preparation method and use thereof SHANGHAI INST MATERIA MEDICA (CN) 2008-11-26 CN claimed
US-12600726-B2 Antagonists of the muscarinic acetylcholine receptor M4 VANDERBILT UNIVERSITY (US) 2026-04-14 US disclosed
EP-3651762-B1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 UNIV VANDERBILT (US) 2024-07-03 EP disclosed
EP-3651762-B1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 UNIV VANDERBILT (US) 2024-07-03 EP disclosed
CN-117736196-A Pyridine amide derivative and application thereof 顺毅股份有限公司 2024-03-22 CN disclosed
CN-116348455-A Protein tyrosine phosphatase inhibitors and methods of use thereof 卡里科生命科学有限责任公司 2023-06-27 CN disclosed
US-20230019236-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF CALICO LIFE SCIENCES LLC (US) 2023-01-19 US disclosed
US-20220048913-A1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2022-02-17 US disclosed
WO-2021139775-A1 PYRIDONE COMPOUND AND APPLICATION 江苏先声药业有限公司 2021-07-15 WO disclosed
WO-2021127499-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF CALICO LIFE SCIENCES LLC (US) 2021-06-24 WO disclosed
CN-1934088-A As 5-HT2c6-substituted 2,3,4, 5-tetrahydro-1H-benzo [ d ] receptor agonists]Aza * LILLY CO ELI (US) 2007-03-21 CN disclosed
CN-1898239-A Novel diazaspiroalkanes and their use in the treatment of CCR8 mediated diseases ASTRAZENECA AB (SE) 2007-01-17 CN disclosed
CN-1711243-A 2-pyridone derivatives as inhibitors of neutrophil elastase ASTRAZENECA AB (SE) 2005-12-21 CN disclosed
CN-1708499-A Purine compounds and their use as cannabinoid receptor ligands PFIZER (US) 2005-12-14 CN disclosed
CN-1649859-A Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE (CH) 2005-08-03 CN disclosed
CN-1505613-A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents ʷ��˿�������ȳ�ķ���޹�˾ 2004-06-16 CN disclosed
CN-1105706-C Cyclic amidino formulations useful as nitric oxide synthase inhibitors SEARLE & CO (US) 2003-04-16 CN disclosed
CN-1305993-A Cyclic guanyl preparation used as nitrogen oxide synthetic enzyme inhibitor SEARLE & CO (US) 2001-08-01 CN disclosed
CN-1189823-A Cyclic amidino formulations useful as nitric oxide synthase inhibitors SEARLE & CO (US) 1998-08-05 CN disclosed
CN-86108233-A The composition of heterogeneous ring compound nematocides and sterilant 1987-09-23 CN disclosed